Back to top
more

MEDIFAST (MED)

(Delayed Data from NYSE)

$18.44 USD

18.44
165,783

+0.16 (0.88%)

Updated Oct 4, 2024 04:00 PM ET

After-Market: $18.46 +0.02 (0.11%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value C Growth A Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 37% (93 out of 252)

Industry: Food - Miscellaneous

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Philip Morris (PM) Q1 Earnings Top Estimates, Revenues Down

by Zacks Equity Research

Philip Morris' (PM) Q1 results benefit from pricing and improved results from the RRPs category. However, the combustible unit continues to be weak.

Will Avon's Open Up Strategy Aid Representative Growth?

by Zacks Equity Research

Avon (AVP) struggles with soft Representatives growth, which is hurting its top-line performance. However, the company's 'Open Up Avon' strategy appears promising.

Hormel Foods Refines Portfolio, Completes CytoSport Sale

by Zacks Equity Research

Post the sale of CytoSport, the Evolve and Muscle Milk brands are no longer part of Hormel Foods' (HRL) business.

Will Sysco's U.S. Foodservice Gain From Sister Firms' Buyout?

by Zacks Equity Research

Sysco (SYY) acquires two Hispanic food distributors to expand customer base and boost long-term growth. This deal will further lift the top line of the company's U.S. Foodservice segment.

Campbell to Exit C-Fresh Business With Bolthouse Farms' Sale

by Zacks Equity Research

Campbell (CPB) inks deal to divest Bolthouse Farms to an affiliate of Butterfly Equity. The deal is expected to conclude by the end of fiscal 2019.

Top Ranked Growth Stocks to Buy for April 15th

by Zacks Equity Research

Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, April 15th

Zacks.com featured expert Kevin Matras highlights: Medifast, Foot Locker, Amedisys, Comfort Systems and CarGurus

by Zacks Equity Research

Zacks.com featured expert Kevin Matras highlights: Medifast, Foot Locker, Amedisys, Comfort Systems and CarGurus

3 Factors That Make Lamb Weston (LW) an Enticing Stock Now

by Zacks Equity Research

Lamb Weston (LW) focuses on LTO innovation. Further, the company is gaining from its strong Global segment and efficient price/mix.

The Zacks Analyst Blog Highlights: MGP Ingredients, Medifast, Ubiquiti Networks, Yield10 Bioscience and Otter Tail

by Zacks Equity Research

The Zacks Analyst Blog Highlights: MGP Ingredients, Medifast, Ubiquiti Networks, Yield10 Bioscience and Otter Tail

4 Factors That Make General Mills (GIS) a Delightful Stock

by Zacks Equity Research

General Mills (GIS) is committed toward boosting market share through innovation. Also, the company is on track with its four key global priorities.

Nalak Das headshot

Low Inflation Data Reduces Rate Hike Possibility: 5 Picks

by Nalak Das

Tamed inflation together with a robust labor market has compelled the Fed to continue with its dovish monetary stance.

Sanghamitra Saha headshot

5 Top-Ranked Stocks to Play DuPont Analysis

by Sanghamitra Saha

Have more faith in DuPont analysis than simple ROE calculation? Bet on these five stocks.

Molson Coors Launches Two Beer Brands Online in Singapore

by Zacks Equity Research

Molson Coors' (TAP) Carling and Blue Moon brands are now available off-premise in Singapore through Amazon Prime Now.

Project Terra to Aid Hain Celestial, Drab FY19 View Hurts

by Zacks Equity Research

Hain Celestial (HAIN) is expected to gain from its Project Terra program and strategic acquisitions amid muted FY19 guidance and soft margins.

Hershey Hits 52-Week High on Robust Buyouts & Saving Efforts

by Zacks Equity Research

Hershey (HSY) has been gaining from its solid brand portfolio, given its focus on innovation and buyouts. Also, the company is on track with its Margin for Growth multi-year program.

Nalak Das headshot

Global Economic Growth Concerns Resurface: 5 Safe Picks

by Nalak Das

Concerns over slowing global growth have contributed to this uncertainty and dented investors' confidence to some extent.

Swarup Gupta headshot

5 Stocks to Prepare for a Global Economic Slowdown

by Swarup Gupta

In such an event, demand for products and services generated by utilities, consumer staples and medical companies remain invariant.

Zacks.com featured expert Kevin Matras highlights: Medifast, lululemon athletica, Fortinet and Kirkland Lake Gold

by Zacks Equity Research

Zacks.com featured expert Kevin Matras highlights: Medifast, lululemon athletica, Fortinet and Kirkland Lake Gold

4 Factors That Make Flowers Foods (FLO) a Delicious Stock

by Zacks Equity Research

Flowers Foods (FLO) is committed toward boosting market share through buyouts. Also, it is on track with Project Centennial.

Newell Down 20% in 3 Months: Is a Turnaround on the Cards?

by Zacks Equity Research

Newell's (NWL) dismal sales surprise trend can be attributed to lower core sales and adverse foreign currency. Nevertheless, its Transformation Plan is encouraging.

Nu Skin Boasts Customer Growth, Faces Weak Gross Margin

by Zacks Equity Research

Nu Skin (NUS) gains from an expanding customer base and prudent product launches. However, persistent decline in gross margin is a concern.

Choose These 4 Liquid Stocks for a Lucrative Portfolio

by Zacks Equity Research

Here are four impressive liquid stocks that are poised to offer marvelous returns.

Kellogg Looks Unappetizing on Rising Costs & Weak Units

by Zacks Equity Research

Kellogg (K) grapples with rising costs and weaknesses in the U.S snacking and cereal categories. The divestiture of certain businesses to Ferrero Group is likely to be a drag.

Clorox (CLX) Thriving on 2020 Strategy & Digital Efforts

by Zacks Equity Research

Clorox (CLX) gains from smooth progress on 2020 Strategy, focus on e-commerce and brand-management initiatives. It also has a robust earnings surprise history.

Medifast (MED) Stock Sinks As Market Gains: What You Should Know

by Zacks Equity Research

Medifast (MED) closed the most recent trading day at $127.29, moving -1.76% from the previous trading session.